The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Germ-line mutations in p27 Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans
Open accessAbstract
MENX is a recessive multiple endocrine neoplasia-like syndrome in the rat. The tumor spectrum in MENX overlaps those of human multiple endocrine neoplasia (MEN) types 1 and 2. We mapped the MenX locus to the distal part of rat chromosome 4, excluding the homologs of the genes responsible for the MEN syndromes ( RET and MEN1 ) and syndromes with an endocrine tumor component ( VHL and NF1 ). We report the fine mapping of the disease locus and the identification of a homozygous frameshift mutation in Cdkn1b , encoding the cyclin-dependent kinase inhibitor p27 Kip1 . As a consequence of the mutation, MENX-affected rats show dramatic reduction in p27 Kip1 protein. We have identified a germ-line nonsense mutation in the human CDKN1B gene in a MEN1 mutation-negative patient presenting with pituitary and parathyroid tumors. Expanded pedigree analysis shows that the mutation is associated with the development of an MEN1-like phenotype in multiple generations. Our findings demonstrate that germ-line mutations in p27 Kip1 can predispose to the development of multiple endocrine tumors in both rats and humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
Montagnoli, A., Fiore, F., Eytan, E., Carrano, A. C., Draetta, G. F., Hershko, A., & Pagano, M. (1999) · Genes & Development · doi:10.1101/gad.13.9.1181 · Cited by 597
Specht, K., Richter, T., Müller, U., Walch, A., Werner, M., & Höfler, H. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63985-5 · Cited by 485
Self-citationMenin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
Milne, T. A., Hughes, C. M., Lloyd, R., Yang, Z., Rozenblatt-Rosen, O., Dou, Y., Schnepp, R. W., Krankel, C., LiVolsi, V. A., Gibbs, D., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408836102 · Cited by 469
Karnik, S. K., Hughes, C. M., Gu, X., Rozenblatt-Rosen, O., McLean, G. W., Xiong, Y., Meyerson, M., & Kim, S. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503484102 · Cited by 403
Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
Kawamata, N., Roberta Morosetti, A., Miller, C. W., Park, D., Spirin, K. S., Nakamaki, T., Takeuchi, S., Hatta, Y., Simpson, J. F., & Wilcyznski, S. (1995) · PubMed · Cited by 340
Zhang, P., Wong, C., DePinho, R. A., Harper, J. W., & Elledge, S. J. (1998) · Genes & Development · doi:10.1101/gad.12.20.3162 · Cited by 309
Philipp-Staheli, J., Payne, S. R., & Kemp, C. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5143 · Cited by 293
p27/Kip1 mutation found in breast cancer.
Spirin, K. S., Simpson, J., Takeuchi, S., Kawamata, N., Cw, M., & Koeffler, H. P. (1996) · PubMed · Cited by 190
Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T- cell leukemia/lymphoma
Roberta Morosetti, A., Kawamata, N., Gombart, A., Cw, M., Hatta, Y., Hirama, T., Jw, S., Tomonaga, M., & Koeffler, H. (1995) · Blood · doi:10.1182/blood.v86.5.1924.bloodjournal8651924 · Cited by 134
Recessive transmission of a multiple endocrine neoplasia syndrome in the rat.
Fritz, A., Walch, A. K., Piotrowska, K., et al. (2002) · PubMed · Cited by 121
Dong, Q., Debelenko, L. V., Chandrasekharappa, S. C., Emmert‐Buck, M. R., Zhuang, Z., Guru, S. C., Manickam, P., Skarulis, M. C., Lubensky, I. A., Liotta, L. A., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3944 · Cited by 120
TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies
Sato, Y., Suto, Y., Pietenpol, J. A., Golub, T. R., Gilliland, D. G., Em, D., Beau, M. M. L., Roberts, J., Vogelstein, B., & Rowley, J. (1995) · Blood · doi:10.1182/blood.v86.4.1525.bloodjournal8641525 · Cited by 109
Analysis of Signal Transducer and Activator of Transcription 3 (Stat 3) Pathway in Multiple Myeloma
Quintanilla-Martinez, L., Kremer, M., Specht, K., Calzada-Wack, J., Nathrath, M., Schaich, R., Höfler, H., & Fend, F. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64278-2 · Cited by 93
Self-citationFilipiak, B. C., Heinrich, J., Schäfer, T., Ring, J., & Wichmann, H. ‐. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01246.x · Cited by 74
Role of MEN2A-Derived RET in Maintenance and Proliferation of Medullary Thyroid Carcinoma
Drosten, M., Hilken, G., Bockmann, M. R., Rödicker, F., Mise, N., Cranston, A. N., Dahmen, U., Ponder, B. A. J., & Pützer, B. M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh226 · Cited by 71
Kalejta, R. F., Brideau, A. D., Banfield, B. W., & Beavis, A. J. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4427 · Cited by 62
Mapping of a novel MEN-like syndrome locus to rat Chromosome 4
Piotrowska, K., Pellegata, N. S., Rosemann, M., Fritz, A., Graw, J., & Atkinson, M. J. (2004) · Mammalian Genome · doi:10.1007/s00335-003-3027-8 · Cited by 50
Self-citationMultiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance
Glascock, J. M., & Carty, S. E. (2002) · Surgical Oncology · doi:10.1016/s0960-7404(01)00031-7 · Cited by 49
p27KIP1 Deletions in Childhood Acute Lymphoblastic Leukemia
Komuro, H., Valentine, M. B., Rubnitz, J. E., Saito, M., Raimondi, S. C., Carroll, A. J., Yi, T., Sherr, C. J., & Look, A. T. (1999) · Neoplasia · doi:10.1038/sj.neo.7900033 · Cited by 41
Cited by
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Thakker, R. V., Newey, P. J., Walls, G. V., Bilezikian, J., Dralle, H., Ebeling, P. R., Melmed, S., Sakurai, A., Tonelli, F., & Brandi, M. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1230 · Cited by 1,477
CDK inhibitors: Cell cycle regulators and beyond
Besson, A., Dowdy, S. F., & Roberts, J. M. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.01.013 · Cited by 1,152
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Chu, I. M., Hengst, L., & Slingerland, J. M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2347 · Cited by 990
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Wigerup, C., Påhlman, S., & Bexell, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.009 · Cited by 687
Silverberg, S. J., Lewiecki, E. M., Mosekilde, L., Peacock, M., & Rubin, M. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1760 · Cited by 688
Metadata
- Authors
- Pellegata, N. S., Quintanilla-Martinez, L., Siggelkow, H., Samson, E., Bink, K., Höfler, H., Fend, F., Graw, J., & Atkinson, M. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2006-10-17
- Volume
- 103
- Issue
- 42
- Pages
- 15558-15563
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2063821942
- Cited by
- 644
- References
- 25
- FWCI
- 24.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.